Search Results - "BarrÓn, Feliciano"

VISTA/PD-1H: a potential target for non-small cell lung cancer immunotherapy by Hernandez-Martinez, Juan-Manuel, Vergara, Edgar, Zatarain-Barrón, Zyanya Lucia, Barrón-Barrón, Feliciano, Arrieta, Oscar

Get full text

23 Validation of PD-L1 dynamic expression on extracellular vesicles as a predictor of response to immune-checkpoint inhibitors and survival in non-small cell lung cancer patients by Perez, Diego de Miguel, Barrón, Feliciano, Russo, Alessandro, Lara-Mejía, Luis, Gunasekaran, Muthukumar, Cardona, Andrés, Peterson, Christine, Colen, Rivka, Naing, Aung, Mack, Philip, Hirsch, Fred, Adamo, Vincenzo, Arrieta, Oscar, Rolfo, Christian

“…BackgroundImmune-checkpoint inhibitors (ICIs) revolutionized the treatment of advanced non-small cell lung cancer (NSCLC).1–3 To date, tissue PD-L1…”
Get full text

Characteristics and outcomes of thymomas in L atin A merica: Results from over 10 years of experience ( CLICaP‐LATimus ) by Martín, Claudio, Enrico, Diego, Mas, Luis, Patane, Ana Karina, Arrieta, Oscar, Soria, Tannia, Cardona, Andrés F., Ruiz‐Patiño, Alejandro, Ruiz, Rossana, Rioja, Patricia, Lozano, Sophia, Zatarain‐Barrón, Zyanya Lucia, Barrón, Feliciano, Puparelli, Carmen, Tsou, Florencia, Corassa, Marcelo P., Freitas, Helano C., Cordeiro de Lima, Vladmir Cláudio, Rojas, Leonardo, Ordóñez‐Reyes, Camila, Corrales, Luis, Sotelo, Carolina, Rodríguez, July, Ricaurte, Luisa, Ávila, Jenny, Archila, Pilar, Rosell, Rafael, Cuello, Mauricio, Remon, Jordi

“…BackgroundThymomas are a group of rare neoplasms of the anterior mediastinum. The objective of this study was to describe the demographics, clinical…”
Get full text

The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial by Turcott, Jenny G., del Rocío Guillen Núñez, María, Flores-Estrada, Diana, Oñate-Ocaña, Luis F., Zatarain-Barrón, Zyanya Lucia, Barrón, Feliciano, Arrieta, Oscar

“…Background Over one half of the patients diagnosed with advanced lung cancer experience anorexia. In addition to its high incidence, cancer-induced anorexia…”
Get full text

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial by Arrieta, Oscar, Barrón, Feliciano, Ramírez-Tirado, Laura Alejandra, Zatarain-Barrón, Zyanya Lucia, Cardona, Andrés F, Díaz-García, Diego, Yamamoto Ramos, Masao, Mota-Vega, Beatriz, Carmona, Amir, Peralta Álvarez, Marco Polo, Bautista, Yolanda, Aldaco, Fernando, Gerson, Raquel, Rolfo, Christian, Rosell, Rafael

“…Because of socioeconomic factors, many patients with advanced non-small cell lung cancer (NSCLC) do not receive immunotherapy in the first-line setting. It is…”
Get more information

Economic burden of immunotherapy as second-line treatment of patients with advanced non-small-cell lung cancer at a Latin American oncology center by Barron, Feliciano Barron, Cabrera, Luis Antonio, Cardona Zorrilla, Andres Felipe, Arrieta Rodriguez, Oscar Gerardo

“…Abstract only e18376 Background: Lung cancer is the leading cause of cancer-related mortality in México and worldwide. More than 80 percent of lung cancers are…”
Get full text

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy by Barrón, Feliciano, Sánchez, Roberto, Arroyo-Hernández, Marisol, Blanco, Carolina, Zatarain-Barrón, Zyanya L, Catalán, Rodrigo, Ramos-Ramírez, Maritza, Cardona, Andrés F, Flores-Estrada, Diana, Arrieta, Oscar

“…Immune checkpoint inhibitor-related pneumonitis (ICIP) is a potentially life threatening immune-related adverse event (irAE), especially in non-small cell lung…”
Get full text

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies by Arrieta, Oscar, Lara‐Mejía, Luis, Bautista‐GonzÁlez, Elysse, Heredia, David, Turcott, Jenny G., BarrÓn, Feliciano, Ramos‐Ramírez, Maritza, Cabrera‐Miranda, Luis, Salinas Padilla, Miguel Ángel, Aguerrebere, Mercedes, Cardona, Andrés F., Rolfo, Christian, Arroyo‐HernÁndez, Marisol, Soto‐Pérez‐de‐Celis, Enrique, Baéz‐Saldaña, Renata

“…Background Accumulated evidence indicates that patients with lung cancer are a vulnerable population throughout the pandemic. Limited information is available…”
Get full text

Pharmacological management of relapsed/refractory NSCLC with chemical drugs by Karachaliou, Niki, Sosa, Aaron E, Barron, Feliciano Barron, Gonzalez Cao, Maria, Santarpia, Mariacarmela, Rosell, Rafael

“…Lung cancer is the leading cause of cancer death in both genders. In the early stages the disease is asymptomatic and most patients appear with metastasis at…”
Get more information

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations by Arrieta, Oscar, Catalán, Rodrigo, Guzmán-Vazquez, Silvia, Barrón, Feliciano, Lara-Mejía, Luis, Soto-Molina, Herman, Ramos-Ramírez, Maritza, Flores-Estrada, Diana, de la Garza, Jaime

“…Tyrosine-kinase inhibitors (TKIs) have become the cornerstone treatment of patients with non-small cell lung cancer that harbor oncogenic EGFR mutations. The…”
Get full text

The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival by Turcott, Jenny G., Martinez-Samano, Julio E., Cardona, Andrés F., Bassarmal, Suraj Samtani, Ramírez-Tirado, Laura Alejandra, Zatarain-Barrón, Zyanya Lucia, Barrón, Feliciano, Corrales, Luis, Martín, Claudio, Barragán-Castillo, Pablo Alan, Ruiz-Patiño, Alejandro, Flores-Estrada, Diana, Arrieta, Oscar

“…The association between cancer-induced weight-loss (CIWL) and poor clinical outcomes in patients treated with immunotherapy is scarcely understood. We…”
Get full text

Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study by Arrieta, Oscar, Barrón, Feliciano, Maldonado, Federico, Cabrera, Luis, Corona-Cruz, José Francisco, Blake, Monika, Ramírez-Tirado, Laura Alejandra, Zatarain-Barrón, Zyanya Lucia, Cardona, Andrés F., García, Osvaldo, Arén, Osvaldo, De la Garza, Jaime

“…•We assess overall survival of oligometastatic Non-small cell lung cancer patients.•37 patients received radical consolidative therapy (RCT) to primary site…”
Get full text

Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study) by Ruiz-Patiño, Alejandro, Cardona, Andrés Felipe, Arrieta, Oscar, Rolfo, Christian, Gómez, Henry L., Raez, Luis E., Lopes, Gilberto, Zatarain-Barrón, Zyanya Lucia, Ricaurte, Luisa, Zamudio-Molano, Nataly, Rangel, Valentina, Oviedo, Juan, Solano, Maria Paula, Rojas, Leonardo, Corrales, Luis, Martín, Claudio, Mas, Luis, Cuello, Mauricio, Barrón, Feliciano, Otero, Jorge, Carranza, Hernán, Vargas, Carlos, Rosell, Rafael

“…The objectives of this study are to evaluate the relationship between authorship networking, socioeconomic factors, and scientific productivity across Latin…”
Get full text

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer by de Miguel-Perez, Diego, Russo, Alessandro, Arrieta, Oscar, Ak, Murat, Barron, Feliciano, Gunasekaran, Muthukumar, Mamindla, Priyadarshini, Lara-Mejia, Luis, Peterson, Christine B, Er, Mehmet E, Peddagangireddy, Vishal, Buemi, Francesco, Cooper, Brandon, Manca, Paolo, Lapidus, Rena G, Hsia, Ru-Ching, Cardona, Andres F, Naing, Aung, Kaushal, Sunjay, Hirsch, Fred R, Mack, Philip C, Serrano, Maria Jose, Adamo, Vincenzo, Colen, Rivka R, Rolfo, Christian

“…Immune-checkpoint inhibitors (ICIs) changed the therapeutic landscape of patients with lung cancer. However, only a subset of them derived clinical benefit and…”
Get full text

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer by Soberanis Pina, Pamela, Lara-Mejía, Luis, Matias-Cruz, Venecia, Barrón, Feliciano, Cardona, Andrés F, Raez, Luis E, Rios-Garcia, Eduardo, Arrieta, Oscar

“…Lung cancer (LC) is one of the most common causes of death worldwide. The identification of oncogene-addicted driving mutations suitable for targeted therapy…”
Get full text

Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial) by Arrieta, Oscar, Maldonado, Federico, Turcott, Jenny G., Zatarain-Barrón, Zyanya Lucia, Barrón, Feliciano, Blake-Cerda, Mónika, Cabrera-Miranda, Luis Antonio, Cardona, Andrés F., de la Garza, Jaime G., Rosell, Rafael

“…To date, studies regarding the use of prophylactic cranial irradiation (PCI) versus standard of care (SoC) for patients with non-small cell lung cancer (NSCLC)…”
Get full text

Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial by Arrieta, Oscar, Zatarain-Barrón, Zyanya Lucia, Turcott, Jenny G, Barrón, Feliciano, Yendamuri, Sai, Cardona, Andrés F, Rosell, Rafael

Get more information

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP) by Cardona, Andrés F, Rojas, Leonardo, Zatarain-Barrón, Zyanya Lucia, Ruiz-Patiño, Alejandro, Ricaurte, Luisa, Corrales, Luis, Martín, Claudio, Freitas, Helano, Cordeiro de Lima, Vladmir Cláudio, Rodriguez, July, Avila, Jenny, Bravo, Melissa, Archila, Pilar, Carranza, Hernán, Vargas, Carlos, Otero, Jorge, Barrón, Feliciano, Karachaliou, Niki, Rosell, Rafael, Arrieta, Oscar

“…Lung cancer is a heterogeneous disease. Presentation and prognosis are known to vary according to several factors, such as genetic and demographic…”
Get full text

Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries by Cardona, Andrés F., Arrieta, Oscar, Ruiz-Patiño, Alejandro, Sotelo, Carolina, Zamudio-Molano, Nataly, Zatarain-Barrón, Zyanya Lucia, Ricaurte, Luisa, Raez, Luis, Álvarez, Marco Polo Peralta, Barrón, Feliciano, Rojas, Leonardo, Rolfo, Christian, Karachaliou, Niki, Molina-Vila, Miguel Angel, Rosell, Rafael

“…Precision oncology is the field that places emphasis on the diagnosis and treatment of tumors that harbor specific genomic alterations susceptible to…”
Get full text

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group by Arrieta, Oscar, Cardona, Andrés F., Lara-Mejía, Luis, Heredia, David, Barrón, Feliciano, Zatarain-Barrón, Zyanya Lucia, Lozano, Francisco, de Lima, Vladmir Cordeiro, Maldonado, Federico, Corona-Cruz, Francisco, Ramos, Maritza, Cabrera, Luis, Martin, Claudio, Corrales, Luis, Cuello, Mauricio, Arroyo-Hernández, Marisol, Aman, Enrique, Bacon, Ludwing, Baez, Renata, Benitez, Sergio, Botero, Antonio, Burotto, Mauricio, Caglevic, Christian, Ferraris, Gustavo, Freitas, Helano, Kaen, Diego Lucas, Lamot, Sebastián, Lyons, Gustavo, Mas, Luis, Mata, Andrea, Mathias, Clarissa, Muñoz, Alvaro, Patane, Ana Karina, Oblitas, George, Pino, Luis, Raez, Luis E., Remon, Jordi, Rojas, Leonardo, Rolfo, Christian, Ruiz-Patiño, Alejandro, Samtani, Suraj, Viola, Lucia, Viteri, Santiago, Rosell, Rafael

“…The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As…”
Get full text